FDA Clearance Tracker · P950019-S014
RAY TFC AND RAY TFC UNITE
Last checked: Nov 20, 2026Latest source record: Mar 25, 2004 (this decision)Source: openFDAMethods & limitations
Decided
Mar 25, 2004
Approved
Time to decision
406 days
Received Feb 13, 2003. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class II
The decision
- FDA number
- P950019-S014
- Device name
- RAY TFC AND RAY TFC UNITE
- Applicant
- Stryker Spine
- Applicant location
- Allendale, NJ
- Received
- Feb 13, 2003
- Decided
- Mar 25, 2004
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Express GMP Supplement
- Original approval
- P950019
Device type
- Device class
- Class II
- Regulation
- 21 CFR 888.3080
- Specialty
- Orthopedic SurgerySpine
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE LOCATED AT STRYKER SPINE, CESTAS, FRANCE.
Source documents
Other decisions for Stryker Spine
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262061 · Decided Jul 17, 2026 · 29 days after receipt
Device type: Intervertebral Fusion Device With Bone Graft, Cervical (ODP) · Orthopedic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.